Table 4.
The result of scenario analyses presented as ICER
| Scenario | ICER ($ per QALY) |
|---|---|
| Price for dapagliflozin | |
| Reduced by 20% | 9305.65 |
| Reduced by 40% | 6745.98 |
| Reduced by 60% | 4186.31 |
| Time horizon | |
| 5 years | 27 599.35 |
| 10 years | 15 591.11 |
| 15 years | 11 865.33 |
| Hospital level | |
| Town hospital | 12 556.94 |
| County hospital | 12 372.18 |
| Municipal hospital | 11 865.33 |
| Provincial hospital | 11 712.85 |
| Ministerial hospital | 10 440.18 |
| LVEF | |
| ≤30% | 4882.72 |
| >30 and ≤37% | 10 294.79 |
| >37 and ≤44% | 6105.52 |
| >44 and ≤51% | 11 550.49 |
| >51 and ≤60% | 64 243.96 |
| >60% | 4646.05 |
| Pooled cohort | 7540.01 |
| Age | |
| <55 years old | −69 232.60 |
| 55–64 years old | −15 836.80 |
| 65–74 years old | 8440.93 |
| ≥75 years | 7612.60 |
| Frailty index (FI) | |
| FI ≤ 0.210 (not frail) | 12 861.62 |
| FI 0.211–0.310 (more frail) | −14 1465.00 |
| FI ≥ 0.311 (most frail) | 41 75.17 |
ICER, incremental cost‐effectiveness ratio; LVEF, left ventricular ejection fraction; QALY, quality‐adjusted life‐year.